Hier beginnt der Kopfbereich - Meta-Navigation und Logos

Kein Link zur Sprachversion DE DE

Hier beginnt die Unternavigation für den Bereich

Ihr Ausdruck wurde in der folgenden Navigationsebene erstellt:

Hier beginnt der Inhaltsbereich
Welcome to the University Hospital as Employer
Visual Content 1
Visual Content 2


Whole genome sequencing enabled the detection of a colistin-resistant hypermutating Citrobacter werkmanii strain harbouring a novel metallo-beta-lactamase VIM-48. Peter S,Bezdan D, Oberhettinger P, Vogel W, Dörfel D, Dick J, Marschal M, Liese J, Weidenmaier C, Autenrieth I, Ossowski S, Willmann M. Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30018-9. doi: 10.1016/j.ijantimicag.2018.01.015. [Epub ahead of print]


Genomic characterisation of clinical and environmental Pseudomonas putida group strains and determination of their role in the transfer of antimicrobial resistance genes to Pseudomonas aeruginosa Peter S.; Oberhettinger P.; Schuele L.; Dinkelacker A.; Vogel W.; Dörfel D.; Bezdan D.; Ossowski S.; Marschal M.; Liese J.; Willmann M. BMC Genomics, 2017 Nov 10;18(1):859. doi: 10.1186/s12864-017-4216-2.


Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens. Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. J Clin Microbiol. 2017 Jul;55(7):2116-2126. doi: 10.1128/JCM.00181-17. Epub 2017 Apr 26.


A simple statistical test of taxonomic or functional homogeneity using replicated microbiome sequencing samples. Huson DH, Steel M, El-Hadidi M, Mitra S, Peter S*, Willmann M*. *contributing equally J Biotechnol. 2017 May 20;250:45-50. doi: 10.1016/j.jbiotec.2016.10.020. Epub 2016 Oct 27.


Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany. Wendel AF, Kaase M, Autenrieth IB, Peter S, Oberhettinger P, Rieber H, Pfeffer K, MacKenzie CR, Willmann M. Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01880-16. doi: 10.1128/AAC.01880-16.


Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A, Baumert P, Hamprecht A, Rohde A, Peter S, Feihl S, Knobloch J, Gölz H, Kola A, Obermann B, Querbach C, Willmann M, Gebhardt F, Tacconelli E, Gastmeier P, Seifert H, Kern WV; DZIF-ATHOS Study Group..
Diagn Microbiol Infect Dis. 2016 Sep 23. pii: S0732-8893(16)30311-X. doi: 10.1016/j.diagmicrobio.2016.09.012.



„Mikrobiom und Metagenom – Präanalytik, DNA Extraktion und Next-Generation Sequencing aus Stuhlproben“ in „Mikrobiom: Wissensstand und Perspektive“, Fedja Farowski, Oliver Bachmann, Tony Bruns, Felix Goeser, Christoph Högenauer, Ernst Holler, Wolfgang Holtmeier, Jutta Keller, Patrizia Kump, Kathleen Lange, Peter Malfertheiner, Harald Matthes, Silke Peter, Natali Pflug, Hans Proquitte, Wolfgang Reindl, Elke Roeb, Carsten Schmidt, Christian Schulz, Hortense Slevogt, Philipp Solbach, Daniel Stößel, Christoph Thöringer, Marius Vital, Daniela Weber, Sebastian Zeißig, Martin Bürger, 2016/10/10, A Stallmach und M Vehreschild (Herausgeber), Walter de Gruyter GmbH & Co KG ISBN-10: 3110452499

Translational metagenomics and the human resistome: confronting the menace of the new millennium.
Willmann M and Peter S.
J Mol Med (Berl). 2016 Oct 20. [Epub ahead of print] Review.


Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. Hamprecht A, Rohde AM, Behnke M, Feihl S, Gastmeier P, Gebhardt F, Kern WV, Knobloch JK, Mischnik A, Obermann B, Querbach C, Peter S, Schneider C, Schröder W, Schwab F, Tacconelli E, Wiese-Posselt M, Wille T, Willmann M, Seifert H, Zweigner J; DZIF-ATHOS Study Group. J Antimicrob Chemother. 2016 Oct;71(10):2957-63. doi: 10.1093/jac/dkw216. Epub 2016 Jun 17.

Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics.
Willmann M, El-Hadidi M, Huson DH, Schütz M, Weidenmaier C, Autenrieth IB, Peter S.
Antimicrob Agents Chemother. 2015 Dec;59(12):7335-45. doi: 10.1128/AAC.01504-15.

Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.
Buhl M, Peter S, Willmann M.
Expert Rev Anti Infect Ther. 2015;13(9):1159-70. doi: 10.1586/14787210.2015.1064310. Review

Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study.
Willmann M, Bezdan D, Zapata L, Susak H, Vogel W, Schröppel K, Liese J, Weidenmaier C, Autenrieth IB, Ossowski S, Peter S.
J Antimicrob Chemother. 2015 May;70(5):1322-30. doi: 10.1093/jac/dku546.

Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.
Willmann M, Klimek AM, Vogel W, Liese J, Marschal M, Autenrieth IB, Peter S, Buhl M.
BMC Infect Dis. 2014 Dec 10;14:650. doi: 10.1186/s12879-014-0650-9.

Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
Büchler AC, Rampini SK, Stelling S, Ledergerber B, Peter S, Schweiger A, Ruef C, Zbinden R, Speck RF.
BMC Infect Dis. 2014 Nov 26;14:607. doi: 10.1186/s12879-014-0607-z.
A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ, Hamprecht A, Peterson L, Schubert S, Häntschel M, Peter S, Schafhausen P, Rohde H, Lilienfeld-Toal MV, Bekeredjian-Ding I, Libam J, Hellmich M, Vehreschild JJ, Cornely OA, Seifert H.
J Antimicrob Chemother. 2014 Dec;69(12):3387-92. doi: 10.1093/jac/dku305.


Emergence of Citrobacter freundii carrying IMP-8 metallo-?-lactamase in Germany
S. Peter, C. Wolz, M. Kaase, M. Marschal, B. Schulte, W. Vogel, I. Autenrieth and M. Willmann
New Microbes and New Infections, Volume 2, Issue 2,  pages 42-45, March 2014


Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium Sedlacek L, Graf B, Schwarz C, Albert F, Peter S, Würstl B, Wagner S, Klotz M, Becker A, Haase G, Laniado G, Kahl B, Suerbaum S, Seibold M, Tintelnot Journal of Cystic fibrosis pii: S1569-1993(14)00311-7. doi: 10.1016/j.jcf.2014.12.014.


Evaluation of phenotypic detection methods for metallo-β-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosaPeter S, Lacher A, Marschal M, Hölzl F, Buhl M, Autenrieth I, Kaase M, Willmann M. Eur J Clin Microbiol Infect Dis. 2014 Jan 23.

Effect of metallo-?-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.
Willmann M, Kuebart I, Marschal M, Schröppel K, Vogel W, Flesch I, Markert U, Autenrieth IB, Hölzl F, Peter S.
BMC Infect Dis. 2013 Nov 1;13:515. doi: 10.1186/1471-2334-13-515.

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, Held J, Peter S, Schumacher U, Buchheidt D, Tintelnot K, Groß U; MykoLabNet-D Partners.
Antimicrob Agents Chemother. 2013 Aug;57(8):3513-7. doi: 10.1128/AAC.00167-13. Epub 2013 May 13.
Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection.
Willmann M, Kuebart I, Vogel W, Flesch I, Markert U, Marschal M, Schröppel K, Autenrieth IB, Hölzl P, Peter S.
J Infect. 2013 Jun 29. pii: S0163-4453(13)00180-1. doi: 10.1016/j.jinf.2013.06.012.
Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa
Willmann M, Marschal M, Hölzl F, Schröppel K, Autenrieth IB, Peter S.
Antimicro Agents Chemother. 2013 Apr;57(4):1797-803. doi: 10.1128/AAC.02142-12. Epub 2013 Feb 4.
Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.
Peter-Getzlaff S, Polsfuss S, Poledica M, Hombach M, Giger J, Böttger EC, Zbinden R, Bloemberg GV.
J Clin Microbiol. 2011 Aug;49(8):2924-32. Epub 2011 Jun 8.
Detection and identification of Mycobacterium spp. in clinical specimens by combining the Roche Cobas Amplicor Mycobacterium tuberculosis assay with Mycobacterium genus detection and nucleic acid sequencing.
Peter-Getzlaff S, Lüthy J, Voit A, Bloemberg GV, Böttger EC.
J Clin Microbiol. 2010 Nov;48(11):3943-8. Epub 2010 Sep 8.
Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy.
Cusini A, Günthard HF, Weber R, Huber M, Kamarashev J, Bertisch B, Peter S, Beck B.
BMJ Case Rep. 2009;2009. pii: bcr05.2009.1904. Epub 2009 Dec 1.
Development and evaluation of a molecular assay for detection of nontuberculous mycobacteria by use of the cobas amplicor platform.
Peter-Getzlaff S, Lüthy J, Böddinghaus B, Böttger EC, Springer B.
J Clin Microbiol. 2008 Dec;46(12):4023-8. Epub 2008 Oct 22.
Defining targets for complement components C4b and C3b on the pathogenic neisseriae
Lewis LA, Ram S, Prasad A, Gulati S, Getzlaff S, Blom AM, Vogel U, Rice PA.
Infect Immun. 2008 Jan;76(1):339-50. Epub 2007 Nov 5
Diagnostic value of molecular confirmation assays for Neisseria gonorrhoeae
Peter-Getzlaff S, Luethy J, Springer B.
J Clin Microbiol. 2007 Nov;45(11):3856; author reply 3856-8.
Neisserial Lipooligosaccharide Is a Target for Complement Component C4b; Inner Core Phosphoethanolamine residues define C4b linkage specificity
Sanjay Ram, Andrew D. Cox, J. Claire Wright, Ulrich Vogel, Silke Getzlaff, Ryan Boden, Jianjun Li, Joyce S. Plested, Seppo Meri, Sunita Gulati, Daniel C. Stein, James C. Richards, E. Richard Moxon, Peter A. Rice
J Biol Chem. 2003 Dec 19;278(51):50853-62. Epub 2003 Oct 2.


Hier beginnt die Marginalspalte Suche und verschieden Module
Quick navigation

Hier beginnt die Fusszeile - Impressum und Datenschutz
Cookie settings
please choose one of the following options to continue.
Further information about the options of your cookie settings you find under help.
To continue, please choose one of the following options

Allow cookies:
We use analytic tools (google analyticx, matomo) to rate visitor information like browser, country or duration of stay on our website. Your IP-address will therefore be anonymously transferred. The Google connection is encrypted.

Only allow necessary cookies:
We don't use analytic tools to rate visitor information. Only cookies which are necessary for technical reasons such as frictionless navigation are used (e.g. for login to restricted areas of our website).

You can change your cookie settings anytime on our data privacy page . To Imprint.


Allow cookies Only allow necessary cookies